Global Bio-identical Hormone Replacement Therapy Market Insights, Forecast to 2030

Publication ID:

PB509244559

Publication Date:

September 25, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Bioidentical hormone replacement therapy (BHRT) is the use of hormones that are identical on a molecular level with endogenous hormones in hormone replacement therapy.
Market Analysis and Insights: Global Bio-identical Hormone Replacement Therapy Market
The global Bio-identical Hormone Replacement Therapy market is projected to grow from US$ 6519 million in 2024 to US$ 9405.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.
The growing frequency of hormonal imbalance illnesses also aids the bioidentical hormone market's expansion. The health safety of the molecule bioidentical hormone, on the other hand, acts as a market restraint. The hormonal levels discovered in a patient with a hormonal imbalance are used to create customised bioidentical hormonal replacements. Additionally, the growing R&D activities by the key players for the discovery of novel therapeutics to treat hormonal imbalances and rising product approvals are expected to aid in the growth of the studied market over the forecast period. However, the high cost of hormone replacement therapy and the risk of developing cancers with HRTs are anticipated to hamper the market growth globally. Additionally, the rise and expansion of the healthcare sector, driven by both public and private actors, particularly in developing nations, will present profitable prospects for the personal health devices market. The market growth rate is also being supported by the governmental healthcare facilities' increased adoption of bioidentical hormone replacement therapy.
Report Covers:
This report presents an overview of global market for Bio-identical Hormone Replacement Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Bio-identical Hormone Replacement Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Bio-identical Hormone Replacement Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bio-identical Hormone Replacement Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Bio-identical Hormone Replacement Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Bio-identical Hormone Replacement Therapy revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
RevitaLife
SottoPelle
JumpstartMD
BioTE Medical
Aesthetic Everything
Segment by Type
Creams
Injections
Implanted Pellets
Patches
Gels
Segment by Application
Men
Women
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Bio-identical Hormone Replacement Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bio-identical Hormone Replacement Therapy companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bio-identical Hormone Replacement Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bio-identical Hormone Replacement Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Creams
1.2.3 Injections
1.2.4 Implanted Pellets
1.2.5 Patches
1.2.6 Gels
1.3 Market by Application
1.3.1 Global Bio-identical Hormone Replacement Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Men
1.3.3 Women
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bio-identical Hormone Replacement Therapy Market Perspective (2019-2030)
2.2 Global Bio-identical Hormone Replacement Therapy Growth Trends by Region
2.2.1 Bio-identical Hormone Replacement Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bio-identical Hormone Replacement Therapy Historic Market Size by Region (2019-2024)
2.2.3 Bio-identical Hormone Replacement Therapy Forecasted Market Size by Region (2025-2030)
2.3 Bio-identical Hormone Replacement Therapy Market Dynamics
2.3.1 Bio-identical Hormone Replacement Therapy Industry Trends
2.3.2 Bio-identical Hormone Replacement Therapy Market Drivers
2.3.3 Bio-identical Hormone Replacement Therapy Market Challenges
2.3.4 Bio-identical Hormone Replacement Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Bio-identical Hormone Replacement Therapy by Players
3.1.1 Global Bio-identical Hormone Replacement Therapy Revenue by Players (2019-2024)
3.1.2 Global Bio-identical Hormone Replacement Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Bio-identical Hormone Replacement Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Bio-identical Hormone Replacement Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Bio-identical Hormone Replacement Therapy Market Concentration Ratio
3.4.1 Global Bio-identical Hormone Replacement Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bio-identical Hormone Replacement Therapy Revenue in 2023
3.5 Global Key Players of Bio-identical Hormone Replacement Therapy Head office and Area Served
3.6 Global Key Players of Bio-identical Hormone Replacement Therapy, Product and Application
3.7 Global Key Players of Bio-identical Hormone Replacement Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bio-identical Hormone Replacement Therapy Breakdown Data by Type
4.1 Global Bio-identical Hormone Replacement Therapy Historic Market Size by Type (2019-2024)
4.2 Global Bio-identical Hormone Replacement Therapy Forecasted Market Size by Type (2025-2030)
5 Bio-identical Hormone Replacement Therapy Breakdown Data by Application
5.1 Global Bio-identical Hormone Replacement Therapy Historic Market Size by Application (2019-2024)
5.2 Global Bio-identical Hormone Replacement Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bio-identical Hormone Replacement Therapy Market Size (2019-2030)
6.2 North America Bio-identical Hormone Replacement Therapy Market Size by Type
6.2.1 North America Bio-identical Hormone Replacement Therapy Market Size by Type (2019-2024)
6.2.2 North America Bio-identical Hormone Replacement Therapy Market Size by Type (2025-2030)
6.2.3 North America Bio-identical Hormone Replacement Therapy Market Share by Type (2019-2030)
6.3 North America Bio-identical Hormone Replacement Therapy Market Size by Application
6.3.1 North America Bio-identical Hormone Replacement Therapy Market Size by Application (2019-2024)
6.3.2 North America Bio-identical Hormone Replacement Therapy Market Size by Application (2025-2030)
6.3.3 North America Bio-identical Hormone Replacement Therapy Market Share by Application (2019-2030)
6.4 North America Bio-identical Hormone Replacement Therapy Market Size by Country
6.4.1 North America Bio-identical Hormone Replacement Therapy Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Bio-identical Hormone Replacement Therapy Market Size by Country (2019-2024)
6.4.3 North America Bio-identical Hormone Replacement Therapy Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Bio-identical Hormone Replacement Therapy Market Size (2019-2030)
7.2 Europe Bio-identical Hormone Replacement Therapy Market Size by Type
7.2.1 Europe Bio-identical Hormone Replacement Therapy Market Size by Type (2019-2024)
7.2.2 Europe Bio-identical Hormone Replacement Therapy Market Size by Type (2025-2030)
7.2.3 Europe Bio-identical Hormone Replacement Therapy Market Share by Type (2019-2030)
7.3 Europe Bio-identical Hormone Replacement Therapy Market Size by Application
7.3.1 Europe Bio-identical Hormone Replacement Therapy Market Size by Application (2019-2024)
7.3.2 Europe Bio-identical Hormone Replacement Therapy Market Size by Application (2025-2030)
7.3.3 Europe Bio-identical Hormone Replacement Therapy Market Share by Application (2019-2030)
7.4 Europe Bio-identical Hormone Replacement Therapy Market Size by Country
7.4.1 Europe Bio-identical Hormone Replacement Therapy Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Bio-identical Hormone Replacement Therapy Market Size by Country (2019-2024)
7.4.3 Europe Bio-identical Hormone Replacement Therapy Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Bio-identical Hormone Replacement Therapy Market Size (2019-2030)
8.2 China Bio-identical Hormone Replacement Therapy Market Size by Type
8.2.1 China Bio-identical Hormone Replacement Therapy Market Size by Type (2019-2024)
8.2.2 China Bio-identical Hormone Replacement Therapy Market Size by Type (2025-2030)
8.2.3 China Bio-identical Hormone Replacement Therapy Market Share by Type (2019-2030)
8.3 China Bio-identical Hormone Replacement Therapy Market Size by Application
8.3.1 China Bio-identical Hormone Replacement Therapy Market Size by Application (2019-2024)
8.3.2 China Bio-identical Hormone Replacement Therapy Market Size by Application (2025-2030)
8.3.3 China Bio-identical Hormone Replacement Therapy Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Bio-identical Hormone Replacement Therapy Market Size (2019-2030)
9.2 Asia Bio-identical Hormone Replacement Therapy Market Size by Type
9.2.1 Asia Bio-identical Hormone Replacement Therapy Market Size by Type (2019-2024)
9.2.2 Asia Bio-identical Hormone Replacement Therapy Market Size by Type (2025-2030)
9.2.3 Asia Bio-identical Hormone Replacement Therapy Market Share by Type (2019-2030)
9.3 Asia Bio-identical Hormone Replacement Therapy Market Size by Application
9.3.1 Asia Bio-identical Hormone Replacement Therapy Market Size by Application (2019-2024)
9.3.2 Asia Bio-identical Hormone Replacement Therapy Market Size by Application (2025-2030)
9.3.3 Asia Bio-identical Hormone Replacement Therapy Market Share by Application (2019-2030)
9.4 Asia Bio-identical Hormone Replacement Therapy Market Size by Region
9.4.1 Asia Bio-identical Hormone Replacement Therapy Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Bio-identical Hormone Replacement Therapy Market Size by Region (2019-2024)
9.4.3 Asia Bio-identical Hormone Replacement Therapy Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Bio-identical Hormone Replacement Therapy Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Bio-identical Hormone Replacement Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Bio-identical Hormone Replacement Therapy Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Bio-identical Hormone Replacement Therapy Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Bio-identical Hormone Replacement Therapy Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Bio-identical Hormone Replacement Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Bio-identical Hormone Replacement Therapy Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Bio-identical Hormone Replacement Therapy Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Bio-identical Hormone Replacement Therapy Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Bio-identical Hormone Replacement Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Bio-identical Hormone Replacement Therapy Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Bio-identical Hormone Replacement Therapy Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Bio-identical Hormone Replacement Therapy Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 RevitaLife
11.1.1 RevitaLife Company Details
11.1.2 RevitaLife Business Overview
11.1.3 RevitaLife Bio-identical Hormone Replacement Therapy Introduction
11.1.4 RevitaLife Revenue in Bio-identical Hormone Replacement Therapy Business (2019-2024)
11.1.5 RevitaLife Recent Developments
11.2 SottoPelle
11.2.1 SottoPelle Company Details
11.2.2 SottoPelle Business Overview
11.2.3 SottoPelle Bio-identical Hormone Replacement Therapy Introduction
11.2.4 SottoPelle Revenue in Bio-identical Hormone Replacement Therapy Business (2019-2024)
11.2.5 SottoPelle Recent Developments
11.3 JumpstartMD
11.3.1 JumpstartMD Company Details
11.3.2 JumpstartMD Business Overview
11.3.3 JumpstartMD Bio-identical Hormone Replacement Therapy Introduction
11.3.4 JumpstartMD Revenue in Bio-identical Hormone Replacement Therapy Business (2019-2024)
11.3.5 JumpstartMD Recent Developments
11.4 BioTE Medical
11.4.1 BioTE Medical Company Details
11.4.2 BioTE Medical Business Overview
11.4.3 BioTE Medical Bio-identical Hormone Replacement Therapy Introduction
11.4.4 BioTE Medical Revenue in Bio-identical Hormone Replacement Therapy Business (2019-2024)
11.4.5 BioTE Medical Recent Developments
11.5 Aesthetic Everything
11.5.1 Aesthetic Everything Company Details
11.5.2 Aesthetic Everything Business Overview
11.5.3 Aesthetic Everything Bio-identical Hormone Replacement Therapy Introduction
11.5.4 Aesthetic Everything Revenue in Bio-identical Hormone Replacement Therapy Business (2019-2024)
11.5.5 Aesthetic Everything Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

RevitaLife
SottoPelle
JumpstartMD
BioTE Medical
Aesthetic Everything

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂